Advances in the development of new biomarkers for Alzheimer's disease
Advances in the development of new biomarkers for Alzheimer's disease
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most common type of neurodegenerative dementia. The prevalence of AD is expected to increase as the population ages, placing an additional burden on national healthcare systems. There is a large need for new diagnostic tests that can detect AD at an early stage wit...
Alternative Titles
Full title
Advances in the development of new biomarkers for Alzheimer's disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f56a63ad026244c5a41ddc10feb525cc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f56a63ad026244c5a41ddc10feb525cc
Other Identifiers
ISSN
2047-9158
E-ISSN
2047-9158
DOI
10.1186/s40035-022-00296-z